From the review:
For patients with acute or stable chest pain syndromes, CCTA is a safe and effective diagnostic modality. The strength of CCTA is its high NPV to rule out CAD, which carries independent prognostic value for short- and long-term coronary events, better than any individual or combination of risk factors or any other diagnostic test.
Early CCTA is a viable alternative to stress testing in the triage of patients with an acute chest pain syndrome. By using CCTA, the length of hospital stay is reduced dramatically, allowing for a faster yet safe discharge from the ED or chest pain unit…
For patients with stable chest pain, the clinical benefit of CCTA is less established.